Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody
Biotech
Starry-eyed Star blazes forward with $125M funding boost
Star Therapeutics will use the funds to support its pipeline of bleeding disorder candidates, including phase 3 von Willebrand disease treatment VGA039.
Zoey Becker
Sep 30, 2025 6:30am
'One of the lucky few': Bicara CEO on last year's $326M IPO
Apr 14, 2025 3:59pm
Sanofi, Teva tout midstage win for TL1A antibody in Crohn’s, UC
Dec 17, 2024 10:30am
Alligator lets loose 70% of staff, sinking stock 53%
Dec 2, 2024 10:40am
VC firm, Chinese biotech launch autoimmune-focused Oblenio Bio
Nov 7, 2024 11:35am
MARAbio’s antibody test for autoimmune-related autism nets $19M
Oct 7, 2024 10:00am